5 completed, 3 unknown, 2 terminated. 4 Phase 4, 2 Not applicable, 2 Phase 1, 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Unknown 2, Completed 1, Terminated 1 |
| Not applicable | 2 | Completed 1, Terminated 1 |
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 2 | Completed 1, Unknown 1 |
| Phase 3 | 1 | Completed 1 |
Follow Marvelon: new trials by email Literature Review of Marvelon trials Research Report on Marvelon
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Ethno-bridging Study of Pergoveris in Healthy Premenopausal Participants of Japanese or Caucasian Origin Desogestrel and ethinylestradiol fixed dose combination, Follitropin alfa/lutropin alfa - Fertility | Phase 1 | Completed | Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | 24 | 2025-11-24 | 2026-03-18 |
| Traditional Chinese Medicine, Western Medicine and Low-level Light Therapy（LLLT） for Primary Dysmenorrhea（PD） low level light therapy, DING KUN DAN, Simulated drug of DING KUN DAN - Primary Dysmenorrhea, Traditional Chinese Medicine | Phase 4 | Unknown | Peking Union Medical College Hospital | 480 | 2019-06-22 | 2019-06-25 |
| NuvaRing Versus Marvelon in the Coordination of In Vitro Fertilization Cycles Contraceptives, Oral, Contraceptive, Vaginal ring - Infertility | Phase 4 | Terminated | Clinique Ovo | 7 | 2012-07-01 | 2015-07-27 |
| New Treatments for Troublesome Bleeding in Implanon Users Marvelon - Menstrual Problem | Phase 4 | Unknown | Family Planning Association New South Wales | 200 | 2011-07-01 | 2011-06-29 |
| Evaluation of an Oral Contraceptive Containing 30 mg Ethinyloestradiol and 150 mg Desogestrel on Women's Health Marvelon - Women With PMS | Phase 2 | Unknown | Tehran University of Medical Sciences | 61 | 2010-09-01 | 2010-12-08 |
| Antagonist/Letrozole in Poor Responders letrozole, oral contraceptive (Marvelone), GnRH agonist (buserelin) - Ovarian Stimulation | Phase 1 / Phase 2 | Completed | Yazd Research & Clinical Center for Infertility | 120 | 2008-06-01 | 2013-12-23 |
| Mid-luteal Phase Synchronization of Ovarian Folliculogenesis in Women Marvelon, Nuvaring, Letrozole - Ovarian Follicle | Not applicable | Completed | University of Saskatchewan | 41 | 2007-11-01 | 2010-04-22 |
| Predictive Factors for Ovarian Stimulation Using a Fixed Daily Dose of 200 IU Recombinant FSH (Study 142003)(P05696) Marvelon - Infertility | Phase 4 | Completed | Organon and Co | 442 | 2006-10-01 | 2022-02-04 |
| NuvaRing vs. Oral Contraceptive Pills (OCP) for In-Vitro Fertilization (IVF) Pre-treatment NuvaRing, marvelon - Infertility, In-vitro Fertilization | Not applicable | Terminated | University of Toronto | 70 | 2006-02-01 | 2012-10-05 |
| A Clinical Study on Yasmin® vs. Marvelon® in Chinese Women Requiring Contraception Yasmin, Marvelon - Contraception | Phase 3 | Completed | Bayer | 842 | 2003-11-01 | 2009-01-14 |
Infertility (4) · Menstruation Disturbances (1)
Bayer (1) · Clinique Ovo (1) · Family Planning Association New South Wales (1) · Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany (1) · Organon and Co (1) · Peking Union Medical College Hospital (1) · Tehran University of Medical Sciences (1) · University of Saskatchewan (1) · University of Toronto (1) · Yazd Research & Clinical Center for Infertility (1)
Canada (2) · China (2) · Iran (2) · Australia (1) · United Kingdom (1)
Edith Weisberg, MB BS MM (1) · Jacques Kadoch, MD (1) · Kimberly E Liu, MD (1) · Roger A Pierson (1)